77. Uji's 8
URICHECK

1. Executive Summary
Lack of regular screening sessions for seniors can result in undiagnosed health problems, causing
serious threats to their health if left untreated. Another problem is that the world is facing a healthcare
worker shortage[1]. To resolve these two issues, we have invented URICHECK, which enables seniors
to regularly monitor their health using AI and technology, from the comfort of their own homes.

2. Our mission / about the company
Our mission is to diagnose seniors with diseases early through our diaper sensor, URICHECK. Thissystem detects and analyzes substances in urine, then identifies diseases seniors may have. We havedesigned our product so it can be utilized by seniors easily. It can be used simply by attaching ourbiosensors to their diapers to analyze urine and determine diseases that seniors are prone to, such as
Chronic Kidney Disease (CKD), diabetes, liver diseases, and kidney diseases.
Through this product, we aim to protect seniors' health by detecting diseases early and enabling
hospitals to treat diseases in their early stages before they severely harm seniors' health. Early
treatment and diagnosis are especially important for seniors as they are more vulnerable to diseases,
due to their immune systems weakening with age [2]. We hope to assist elderly people to achieve ahealthy lifestyle, by enabling them to access professional treatment when needed, and encouraging
voluntary change in their lifestyle in less severe cases.

3. Product and Service Description
URICHECK is a biosensor that seniors caneasily attach to their diapers in order to allow
early detection and possible treatments. Thebiosensor is capable of detecting 137
substances that are known to exist in urine.
Enzymes and antigens in the biofuel battery
are used to bind substances, and electric currents are passed through them. Then, the data of voltage
strength, which shows the concentrations of these substances, are sent to the AI for processing.
The AI uses K-NN (K- Nearest Neighbour) and SVM (Support Vector Machine) Machine learning models
to analyze urine data and determine diseases based on weight, in a decision tree format. The SVM
algorithm is used to detect diseases. Whether the concentration of a substance in urine (e.g. Ketonebody, protein, glucose) is above or below the critical value, allows the identification of possible diseases.
The K-NN algorithm is used to determine the severity of a specific disease, as it can be implemented inmultiple classes. K-NN compares how close the value for a specific factor (e.g. glucose level) is to thedata of other severity classes in the database, to categorize data based on severity. If the data belongs
to a group of severe conditions, without the possibility of natural recovery, the AI immediately notifies thedoctor, allowing necessary treatment to take place. If natural recovery is possible, the senior and theirfamily are notified of the patient’s current condition. This allows seniors to voluntarily change theirlifestyle according to their condition, in order to improve their health. Since this biosensor is used on adaily basis, seniors and their families can monitor slight changes in health conditions. Clearly, thisbiosensor and AI play the indispensable role of supporting seniors to take action themselves to protect
their own health.

4. Market, Customer Analysis and Marketing
The target customers are seniors, who may have diseases, or seniors already diagnosed with diseases,
for monitoring. The target industry is healthcare facilities, as URICHECK makes monitoring cheaper andmore time efficient. Additionally, within the biosensor market, wearable biosensors hold the highest
compound annual growth rate [3]. Home diagnostic applications are expected to grow at the highest rate
between the years 2021-2026, showing URICHECK’s demand will continue to increase in the comingyears[4]. Additionally, URICHECK is the first biosensor that monitors more than one type of healthcondition, as well as identifying the severity of the disease. This product promotes good health, notdependence as it aids in the diagnosis and treatment of diseases, without changing seniors’ daily
routines. URICHECK is ethical as it’s pain-free and non-invasive, unlike test kits that use needles/insert
microchips inside the patient's body. In addition, it’s easy to use, making it appropriate for seniors. It
increases the good health and well-being of seniors, fulfilling the 3rd SDG goal. As the number ofdoctors available to look after the patients are decreasing, we will use technology to more efficiently
detect and diagnose health issues. We plan to promote this product through doctors, health caresystems, and elderly homes able to persuade seniors who are suitable for this product to purchase it.

5. FinanceOur initial capital investment isrelatively cheap, as our main
operation system is the AI.
Additionally, we will only have to buy
the patient’s data for the first year,
since data is added on.
The production cost of the sensor isexpensive compared to other smart
diaper biosensor businesses.
However, this is due to the advanced
technology and wide range of factorsthat are offered in this product.
Furthermore, the production cost per
sensor will decrease due to theincrease in the economies of scale.
Our business will break even in 1year and 1 month allowing us torepay the loan and pay dividends toshareholders by the third year,
allowing us to increase sales. We will
be profiting from this business
relatively quickly.

7. Conclusion
URICHECK will enable efficient excretion disposal, analysis and identification of diseases.
This is to resolve problems of elderly people unable to use the bathroom, and suffering fromundiagnosed health problems from not receiving frequent check-ups. Our product will contribute to theachievement of the 3rd SDG goal of good health and well-being.

8. References[1]https://www.who.int/health-topics/health-workforce#tab=tab_1[2]www.latrobe.edu.au/news/articles/2020/opinion/why-are-older-people-more-at-risk-of-coronavi
rus\#:~:text=As%20we%20age%2C%20our%20immune,phenomenon%20called%20a%20cytokine%20
storm[3]www.grandviewresearch.com/industry-analysis/biosensors-market[4]www.marketsandmarkets.com/Market-Reports/biosensors-market-798.html